Study guide
5.2 Seizures, Epilepsy & Altered Mental Status
USMLE Step 2 CK Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Human Development & Well-Patient Care
1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening
2 Chapter 2: Immune System & Immunologic Disorders
2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles
3 Chapter 3: Blood & Lymphoreticular System
3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders
4 Chapter 4: Behavioral Health & Psychiatric Disorders
4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology
5 Chapter 5: Nervous System & Special Senses
5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies
6 Chapter 6: Musculoskeletal System & Dermatology
6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders
7 Chapter 7: Cardiovascular System
7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease
8 Chapter 8: Respiratory System
8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases
9 Chapter 9: Gastrointestinal System
9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis
10 Chapter 10: Renal, Urinary & Reproductive Systems
10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease
11 Chapter 11: Pregnancy, Childbirth & Puerperium
11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management
12 Chapter 12: Endocrine System
12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology
13 Chapter 13: Multisystem Processes & Critical Care
13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens
14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation
14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine
15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice
15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions
5.2 Seizures, Epilepsy & Altered Mental Status
Key Takeaways Explain This Topic AI
Status epilepticus is defined as continuous seizure activity lasting 5 minutes or longer, or 2 or more discrete seizures without complete recovery of consciousness between events.
First-line abortive therapy for status epilepticus is intravenous lorazepam (4 mg) or intramuscular midazolam (10 mg); if seizures persist after 5-10 minutes, repeat the dose and administer an IV non-sedating antiepileptic (levetiracetam, fosphenytoin, or valproate).
Absence seizures characteristically exhibit 3 Hz spike-and-wave complexes on EEG, triggered by hyperventilation, and respond specifically to ethosuximide (T-type calcium channel blocker).
Delirium is an acute, fluctuating disturbance in attention and awareness diagnosed clinically using the Confusion Assessment Method (CAM), requiring identification of underlying triggers rather than sedative medication.
In patients presenting with Wernicke encephalopathy, intravenous thiamine (500 mg every 8 hours) must be administered before or concurrently with glucose fluids to prevent irreversible Korsakoff psychosis.
Last updated: July 2026
Emergency Management of Status Epilepticus
Status epilepticus is a major neurological emergency associated with neuronal injury and systemic complications. Operationally, status epilepticus is defined as continuous seizure activity lasting ≥5 minutes or ≥2 discrete seizures between which there is incomplete recovery of consciousness. Neuronal injury accelerates rapidly after 30 minutes of continuous seizure activity.
Phased Treatment Protocol
Management follows a strict, time-sensitive algorithm to abort seizure activity rapidly:
Operational Phase Timeframe Interventions & Medications Dosing & Route
Phase 1: Stabilization 0 to 5 minutes Assess airway, breathing, circulation; apply high-flow oxygen; check point-of-care blood glucose; establish IV access If glucose <60 mg/dL: Administer 50 mL D50W IV + Thiamine 100 mg IV
Phase 2: First-Line Therapy 5 to 20 minutes Parenteral Benzodiazepines (Rapid abortive agent) IV Lorazepam: 4 mg IV over 2 min (0.1 mg/kg); OR IM Midazolam: 10 mg IM (>40 kg); OR IV Diazepam: 10 mg IV. May repeat once at 5–10 min if seizures persist
Phase 3: Second-Line Urgent Control 20 to 40 minutes Non-Sedating IV Antiepileptic Drugs IV Levetiracetam: 60 mg/kg (max 4500 mg); OR IV Fosphenytoin: 20 mg PE/kg (max 1500 mg PE); OR IV Valproate: 40 mg/kg (max 3000 mg)
Phase 4: Refractory Status >40 minutes General Anesthesia & Intubation Continuous IV infusion of Propofol , Midazolam , or Pentobarbital with continuous EEG monitoring targeting burst suppression
Seizure Classification & Epilepsy Syndromes
Accurate classification of seizures as focal or generalized dictates long-term anti-seizure medication (ASM) selection: [ Seizure Presentation ]
- |
- (Clinical History & EEG Evaluation)
- |
- +---------------------------+---------------------------+
- | |
- [ Focal Onset ] [ Generalized Onset ]
- | |
- (Starts in one hemisphere) (Engages both hemispheres)
- | |
- +-------+-------+ +---------------+--------------+
- | | | |
- [ Focal Aware ] [ Focal Impaired ] [ Motor (Tonic-Clonic) ] [ Non-Motor (Absence) ]
- (No loss of (Epigastric aura, (Tongue biting, post-ictal (3 Hz spike-and-wave;
- awareness) lip smacking, amnesia) confusion, 4-6 Hz EEG) ethosuximide responsive)
- Common Epilepsy Syndromes & Diagnostic Features
Absence Seizures: Typically present in school-aged children as sudden, brief (5–15 seconds) episodes of unresponsiveness with blank staring. No post-ictal confusion occurs. Classic EEG finding is 3 Hz generalized spike-and-wave discharges induced by hyperventilation. First-line therapy is ethosuximide (blocks T-type Ca²⁺ channels in the thalamus).
Juvenile Myoclonic Epilepsy (JME): Characterized by brief, involuntary muscle jerks upon awakening in adolescents, often progressing to generalized tonic-clonic seizures. EEG shows 4–6 Hz polyspike-and-wave complexes. First-line treatment is valproic acid or levetiracetam (avoid valproate in females of childbearing potential due to teratogenicity).
Temporal Lobe Epilepsy: Most common cause of focal seizures with impaired awareness in adults. Classically preceded by an epigastric rising aura , deja vu, or olfactory hallucinations, followed by automatisms (lip smacking, hand fumbling) and post-ictal confusion. Associated with mesial temporal sclerosis on MRI. First-line agents include oxcarbazepine , carbamazepine , or levetiracetam .
Acute Altered Mental Status & Delirium
Delirium is an acute, fluctuating disturbance in attention, awareness, and cognition that is particularly prevalent among hospitalized elderly patients.
Distinguishing Delirium, Dementia, and Psychosis
- Clinical Feature Delirium Dementia Primary Psychosis
- Onset Acute (hours to days) Insidious (months to years) Variable (weeks to months)
- Course Fluctuating (symptoms wax/wane) Progressive, stable Chronic, unremitting
- Attention Markedly impaired (hallmark) Preserved until late stages Typically intact
- Level of Consciousness Altered (somnolent or hyperactive) Alert, clear sensorium Alert, clear sensorium
- Reversibility Reversible (upon treating cause) Irreversible Manageable with pharmacotherapy
- Confusion Assessment Method (CAM)
Diagnosis of delirium using the CAM requires the presence of:
Feature 1: Acute Onset and Fluctuating Course AND
Feature 2: Inattention PLUS EITHER:
- Feature 3: Disorganized Thinking OR
- Feature 4: Altered Level of Consciousness
Management Strategy:
Non-Pharmacologic Interventions (First-Line): Reorientation protocols, early ambulation, restoring normal sleep-wake cycles, removing unnecessary urinary catheters and physical restraints, and minimizing night-time room intrusions.
Pharmacologic Interventions: Reserved exclusively for severe agitation posing immediate physical threat to the patient or staff. Low-dose oral haloperidol or atypical antipsychotics (quetiapine) may be used. Avoid benzodiazepines , as they worsen delirium unless treating alcohol withdrawal or benzodiazepine abstinence.
- Toxic-Metabolic Encephalopathies
- Wernicke Encephalopathy & Korsakoff Syndrome
Wernicke encephalopathy is an acute, reversible neuro-metabolic emergency caused by thiamine (Vitamin B1) deficiency , seen predominantly in chronic alcohol use disorder, severe malnutrition, or hyperemesis gravidarum.
Classic Triad:
- Encephalopathy (profound confusion, disorientation)
- Ataxia (broad-based gait instability)
- Oculomotor Dysfunction (horizontal nystagmus, bilateral lateral rectus / CN VI palsy)
Critical Management Rule: Intravenous thiamine (500 mg IV every 8 hours) must be administered BEFORE or concurrently with intravenous glucose solutions . Administering glucose alone accelerates thiamine consumption in the pyruvate dehydrogenase pathway, precipitating irreversible Korsakoff psychosis (characterized by anterograde/retrograde amnesia and confabulation due to destruction of mammillary bodies).
Hepatic Encephalopathy
Reversible neuro-psychiatric impairment resulting from liver failure and portosystemic shunting, causing accumulation of neurotoxins (ammonia, glutamine).
Clinical Presentation: Asterixis (flapping tremor of outstretched hands), sleep reversal, disorientation, and lethargy.
First-Line Therapy: Lactulose (titrated to 2–3 soft stools daily; acidifies gut lumen to convert ammonia NH₃ to non-absorbable ammonium NH₄⁺). Rifaximin is added as second-line therapy to eliminate ammonia-producing colonic bacteria.